New vaccines are being studied for the Australian flu

Professor Giovanni Di Perri, the head of Infectious Diseases at the Amedeo di Savoia Hospital in Turin, discussed the initial cases of A-H3N2 influenza, also known as the “Australian” strain, which is caused by the particularly H3N2 virulent virus. This strain has resulted in many hospitalisations and intensive care admissions in the southern hemisphere. Di Pierri posited that, although the Australian bulletins recorded a slightly higher number of cases than the previous year, this would be a low and consistent increase. Additionally, while the currently circulating strains of influenza virus pose a genuine risk of evolving to infect novel host species, the development of new RNA-messenger vaccines could prove an effective means of countering this evolutionary process. Furthermore, several antiviral medications are currently available for treating influenza, although their usage is not widespread. Finally, several other medications are undergoing clinical trials.